baber/WOPTO huggingface dataset:
Patent DK-0418355-T3 (DK)
Inventor: URBAN GERALD DR
IPC: C12N11/00
Filed: 1990-04-04
Granted: 1994-09-12
Abstract: PCT No. PCT/AT90/00026 Sec. 371 Date Dec. 31, 1990 Sec. 102(e) Date Dec. 31, 1990 PCT Filed Apr. 4, 1990 PCT Pub. No. WO90/12092 PCT Pub. Date Oct. 18, 1990.Reactants containing amino, mercapto or hydroxy groups such as proteins, peptides, ligands, coenzymes or enzymes are immobilized on a support containing amino, mercapto or hydroxy groups by coupling the reactant to the support with a compound having the following formula (I) or (IA):   <IMAGE> (I)  <IMAGE> (IA)  wherein X is a halogen and R1, R2 are the same or different and are X, R, COR, COOR, wherein R is C1-C8 alkyl, COOH, CNS, N3 or CN. The support may be first reacted with the compound to produce a derivatized support which is then reacted the reactant or the reactant may be first reacted with the compound and the resultant product then reacted with the support. An electrochemical biosensor can be prepared by using a conductive support.
Patent DK-0485458-T3 (DK)
Inventor: BRILLON DENIS
IPC: C07D403/12
Filed: 1990-08-03
Granted: 1998-04-20
Abstract: This invention relates to 1-amino thioacylbenzimidazoyl-2-one derivatives having the formula:   <IMAGE>    wherein R1, R2 and R3 are defined herein. These compounds are useful as thioacylating reagents. This invention also relates to a process for producing cyclic and linear thiopeptides using the thioacylating reagents of this invention. This invention further relates to intermediate anilide compounds, which are produced by reacting an ortho phenylene diamine with an amino acid chain or peptide. This invention also relates to intermediate thioanilide compounds, which are produced by thionating the intermediate anilide compounds. This invention further relates to a process for producing the thioacylating reagents of this invention by cyclizing the intermediate thioanilide compounds.
Patent DK-0475216-T3 (DK)
Inventor: STARK MANFRED
IPC: E04B1/19
Filed: 1991-08-30
Granted: 1993-10-18
Abstract: To be able to facilitate or carry out at the factory axial prestressing of the cap screws (12), in the case of screw joints between struts (11) and nodes (10) of a space frame, a number of axially parallel bores (19) are provided in each end piece (15) on one strut (11), concentrically to the passage bore (14). Fastening screws (20) which are screwed into threaded bores (27) in a connection plate (26) are fitted through said bores (19) at the building site. The connection plates (26) are welded to each end of a strut (11). The end pieces (15) are connected to the nodes (10) at the factory via the cap screws (12). 
<IMAGE>
Patent DK-0483616-T3 (DK)
Inventor: SEELE RAINER DR
IPC: C07D521/00
Filed: 1991-10-18
Granted: 1996-01-29
Abstract: Azolylmethylspiro(2.5)octanols of the formula  (* CHEMICAL STRUCTURE *)  where A and R are each hydrogen or alkyl; D is alkyl, cycloalkyl, cycloalkenyl, biphenylyl, naphthyl, hetaryl or phenyl, it being possible for each of these radicals to be substituted; Z is CH2 or O, X is CH or N, and the plant-compatible acid addition salts and metal complexes thereof are used as or in fungicides.
Patent DK-0493779-T3 (DK)
Inventor: HENDERSON JAMES T
IPC: C12N15/70
Filed: 1991-12-23
Granted: 1997-05-26
Abstract: Isolation and identification of a gene encoding for a bacteriocin precursor in Pediococcus acidilactici, cloning of the gene in a vector plasmid and transformation to bacteria is described. The bacteriocin is particularly useful for inhibiting Listeria in food products.
Patent DK-0461972-T3 (DK)
Inventor: MERCIER CLAUDE
IPC: C07C45/51
Filed: 1991-06-10
Granted: 1994-05-02
Abstract: Process for the conversion of N-oxides of tertiary amines to aldehydes by means of a catalyst derived from vanadium, as well as the preparation of unsaturated aldehydes from dienes.
Patent DK-0532177-T3 (DK)
Inventor: JACOBS ROBERT TOMS
IPC: C07D401/06
Filed: 1992-08-11
Granted: 1997-03-24
Abstract: Compounds of formula I, and pharmaceutically acceptable salts thereof, useful in the treatment of neuropsychisatric disoders such as psychoses; pharmaceutical compositions comprising a compound of formula I and a pharmaceutically acceptable diluent or carrier; and methods of treating neuropschiatric disorders comprising administering to a mammal (including man) in need of such treatment an effective amount of a compound of formula I, or a pharmaceutically acceptable salts thereof. <IMAGE>
Patent DK-0498706-T3 (DK)
Inventor: ROSSEY GUY
IPC: C12R1/72
Filed: 1992-02-03
Granted: 1996-02-12
Abstract: In a starting mixture containing the dextrorotatory and levorotatory enantiomers of methyl trans-2,3-epoxy-3-(4-methoxyphenyl)propionate, the dextrorotatory enantiomer is subjected to transesterification in an anhydrous medium, which converts it to an insoluble derivative, in the presence of an enzyme which does not affect the levorotatory enantiomer. The latter is a synthetic intermediate of compounds such as Diltiazem.
Patent DK-0540389-T3 (DK)
Inventor: LINI HEDI
IPC: C13B20/12
Filed: 1992-10-14
Granted: 1996-07-08
Abstract: The treatments of purification or bleaching of aqueous liquids are carried out with the aid of purifying agents consisting of powder of certain active carbons in a water-soluble polyvinyl alcohol jacket. These treatments, which are carried out without any carbon powder being blown into the air, do not leave any detectable trace of polyvinyl alcohol in the treated liquids. Application to the bleaching of stained white wines and of sweet juices.
Patent DK-0577653-T3 (DK)
Inventor: ARWEILER HANS WERNER
IPC: H04B3/46
Filed: 1992-03-19
Granted: 1995-07-03
Abstract: PCT No. PCT/DE92/00239 Sec. 371 Date Sep. 27, 1993 Sec. 102(e) Date Sep. 27, 1993 PCT Filed Mar. 19, 1992 PCT Pub. No. WO92/17949 PCT Pub. Date Oct. 15, 1992The invention relates to a method for determining the transmission characteristics (H(jf)) of an electric line (2) in an ISDN system, in which a test signal (m(t)) is applied to the line (2) at one end, and at the other end of the line (2) the received signal (g(t)) produced owing to the test signal (m(t)) is evaluated. In order to be able to carry out such a method using a test signal having a crest factor of one with relatively little cost, use is made as test signal of a binary, bipolar random number sequence signal (m(t)) having the crest factor of one, and during a time interval corresponding to the period of the test signal (m(t)) the received signal (g(t)) is scanned and subjected to a Fourier transformation to obtain a spectral signal (G(jf)); the latter is complexly multiplied by a reference spectrum Mi(jf) to obtain an output signal (H(jf) which represents a measure of the transmission characteristics of the line (31).
Patent DK-0572537-T3 (DK)
Inventor: BADGER ALISON MARY
IPC: A61K31/445
Filed: 1992-02-18
Granted: 2000-03-27
Abstract: Invented are methods of inhibiting the production of cytokines, particularly inhibiting the production of interleukin-1 and inhibiting the production of tumor necrosis factor in a mammal in need thereof which comprises administering to such mammal an effective amount of an azaspirane derivative.
Patent DK-0592479-T3 (DK)
Inventor: RAVENSTEIJN ROB VAN
IPC: B65D73/00
Filed: 1992-06-26
Granted: 1995-12-04
Abstract: A sales package (1) or holder, consisting of an integral card-type cardboard or paperboard part (2) made of thin, foldable material for the visible display of at least one article (8, 25, 32, 52), at least one region which projects from the plane of the card-type part (2) holding the article, is to be produced with less use of cardboard or paperboard material. This is achieved in that the card-type part (2) is of single-layered construction and has at least one element (3, 4, 15, 15'), which projects like a flap in the shape of a tongue, preferably approximately at right angles, from the card-type part (2), with a receiving opening (6, 7; 7'; 7") for the article (8, 25, 32, 52), the edge of said element forming a stop region for the article. <IMAGE>
Patent DK-0602349-T3 (DK)
Inventor: VIESSMANN HANS DR
IPC: F28D1/06
Filed: 1993-10-21
Granted: 1996-11-25
Abstract: The invention relates to an accumulator with a double shell for preparing and storing hot domestic water, consisting of a container (1) which is provided with a cold-water supply and hot-water discharge connection (3, 4) and is surrounded by an outer shell (2), with a shape adapted to the said container, which conducts the heating medium and on which heating-medium flow and return connections (6, 7) are arranged. In order to improve and simplify such an accumulator with a double shell with regard to its outer-shell termination in such a way that neither the fabrication and welding-in of a separate ring nor a special shaping of the container terminating end is required, according to the invention the storage container (1) is provided, in the region of the end (8) of the outer shell (2), with an outwardly curved circumferential flange (9) and the end edge (10) of the outer shell (2) is welded onto this circumferential flange (9). <IMAGE>
Patent DK-0620854-T3 (DK)
Inventor: REZAIE ALIREZA
IPC: C07K19/00
Filed: 1992-12-29
Granted: 1999-06-14
Abstract: A method is disclosed to make any protein in a form that can be isolated rapidly from a solution using a specific monoclonal antibody designated "HPC-4". It has now been determined that it is possible to form a fusion protein of the epitope with a protein to be isolated, and isolate the protein using HPC-4-based affinity chromatography. In the preferred embodiment, a specific protease cleavage site is inserted between the epitope and the protein so that the epitope can be easily removed from the isolated protein. In an example, a functionally active soluble tissue factor including the twelve amino acid epitope recognized in combination with calcium by HPC-4 and a factor Xa cleavage site was expressed from a vector inserted into a procaryotic expression system. The recombinant tissue factor can be rapidly isolated in a single chromatographic step using the HPC-4 monoclonal antibody immobilized on a suitable substrate. Once isolated, the Protein C epitope is removed by cleavage with factor Xa, leaving the functionally active, soluble tissue factor.
Patent DK-0652985-T3 (DK)
Inventor: GUERLET JEAN-PAUL
IPC: B01J20/26
Filed: 1993-07-22
Granted: 1997-10-13
Abstract: PCT No. PCT/FR93/00752 Sec. 371 Date Jan. 31, 1995 Sec. 102(e) Date Jan. 31, 1995 PCT Filed Jul. 22, 1993 PCT Pub. No. WO94/03665 PCT Pub. Date Feb. 17, 1994A wire comprising at least one helically wound wire element is disclosed. The helical winding consists of a platinoid or platinoid alloy wire (20). Also disclosed are assemblies of these wires (20) such as knitted materials, fabrics and felts, and the use of said assemblies as catalysers in the reaction for preparing nitric or cyanhydric acid, and to recover precious metals from these catalysers.
Patent DK-0666886-T3 (DK)
Inventor: GASTMANS ANDRE C C
IPC: C08L95/00
Filed: 1993-11-01
Granted: 1998-11-30
Abstract: A bitumen emulsion of an anionic or cationic type having a breaking additive is disclosed, wherein the breaking additive has been added to the emulsion in the form of a suspension of a breaking solid in oil. The invention also relates to a breaking additive which comprises a suspension of a breaking solid in oil. The emulsion is prepared by preparing a suspension of a breaking solid in oil and then mixing the suspension with a bitumen emulsion of an anionic or cationic type. The bitumen emulsion can be used in road building, road maintenance, recycling of old asphalt pavings and construction work.
Patent DK-0640616-T3 (DK)
Inventor: ALPERMANN HANS-GEORG DR
IPC: A61P17/00
Filed: 1994-08-22
Granted: 2003-03-24
Abstract: There are described 17-alkyl carbonate-21-carbonic/carboxylic acid esters of corticosteroids of the formula I <IMAGE> where A is CHOH or CHCl, CH2, C = O, a 9(11) double bond; Y is H, F, Cl; Z is H, F, CH3; R(1) is aryl, hetaryl; n and m are zero or 1; R(2) is alkyl, -(CH2)2-OCH3; R(3) is H, methyl. They are obtained by reacting a compound of the formula II <IMAGE> in which R(5) is OH, with an activated carboxylic acid of the formula III  R(6)-CO-(O)n-[(C1-C4)-alkyl]m-R(1)      III The compounds I have very potent local and topical anti-inflammatory activity and show a very good ratio of local to systemic anti-inflammatory action, which is often clearly superior compared with analogous corticoid 17-alkyl carbonate 21-esters which do not carry an aryl or hetaryl group in the 21 ester radical.
Patent DK-0621569-T3 (DK)
Inventor: HAZARD MICHEL
IPC: G06F21/75
Filed: 1994-04-13
Granted: 1999-11-29
Abstract: The present invention relates to a device for protecting keys of a chip card, characterized in that:     - each key is enciphered with the aid of a diversified key; - a protection entity, corresponding to an entity dependent on each enciphered key, is generated and associated with each enciphered key;   - a means of detection installed in the card allows the integrity of the key to be verified, by comparing the protection entity with a verification entity generated from the key of the card, by the means of detection of the card; - a means of blocking allows the blocking of any subsequent calculation on the key in the case where the verification entity is not identical to the protection entity.   <IMAGE>
Patent DK-0679540-T3 (DK)
Inventor: AMICI GIAMPIERO
IPC: B60B17/00
Filed: 1994-04-27
Granted: 1997-12-08
Abstract: An improved elastic wheel (10) is provided, between tyre (12) and wheel-center (18) connected to an intermediate ring (16), with several V-shaped metal blocks, covered with elastomeric material (30'), alternating with analogous and conventional rubber blocks (32). Covering (30') is obtained by vulcanization on the upper and lower fronts of blocks (30) for a thickness comprised preferably between 0.5 and 3 mm; said blocks (30) have a thickness slightly lower than rubber blocks (32), which have a greater length. Metal blocks (30) restrict the shiftings of tyre (12) relatively to wheel-center (18), both in the radial and in the axial directions, stiffening the whole structure of wheel (10) and acting as a side ledge for the aforementioned tyre on the opposing fronts. <IMAGE>
Patent DK-0652960-T3 (DK)
Inventor: BEAVO JOSEPH A
IPC: C12N9/16
Filed: 1994-05-27
Granted: 2001-04-17
Abstract: The present invention provides novel purified and isolated nucleotide sequences encoding the cGMP-binding, cGMP-specific phosphodiesterase designated cGB-PDE. Also provided by the invention are methods and materials for the recombinant production of cGB-PDE polypeptide products and methods for identifying compounds which modulate the enzymatic activity of cGB-PDE polypeptides. <IMAGE>
Patent DK-0717799-T3 (DK)
Inventor: KNAPICK EDWARD G
IPC: C05G3/80
Filed: 1994-08-26
Granted: 2000-10-02
Abstract: The present invention provides granules obtained from waste paper, said granules comprising inorganic fillers including kaolin clay, and organic material including cellulose fibres, characterized in that the granules contain less than 10% by weight of cellulose fibres having a length greater than 1 mm. These granules have a high resistance to attrition and can be used as an absorbent material, an agricultural carrier or an animal litter. <IMAGE>
Patent DK-0759740-T3 (DK)
Inventor: YVIN JEAN-CLAUDE
IPC: A61Q11/00
Filed: 1995-05-11
Granted: 2001-11-05
Abstract: PCT No. PCT/FR95/00618 Sec. 371 Date Nov. 7, 1996 Sec. 102(e) Date Nov. 7, 1996 PCT Filed May 11, 1995 PCT Pub. No. WO95/31177 PCT Pub. Date Nov. 23, 1995A cosmetic or pharmaceutical, particularly dermatological, composition including an effective amount of laminarin or laminarin-derived oligosaccharides as the active ingredient. It has been discovered that laminarin, oligosaccharides derived therefrom and compositions containing same have stimulating, regenerating, conditioning and energising effects on human dermis fibroblasts and human epidermis keratinocytes. Said composition is useful in cosmetics and pharmacology.
Patent DK-0782380-T3 (DK)
Inventor: TUTSCHKA ALFRED
IPC: A01D34/66
Filed: 1995-09-21
Granted: 1999-04-26
Abstract: The invention concerns a sickle mowing machine having a rotatable blade (12, 14, 16) which is substantially surrounded over its periphery and at the top by a cover (46). The blade (12, 14, 16) comprises an upwardly directed guide arrangement (32) and a downwardly directed guide arrangement (42) which swirl mowed material upwards and urge it down to the ground again. The mowed material thus passes several times into the cutting region of the blade (12, 14, 16) and is thus comminuted ("pulverized") a number of times. In order to be able to mow a broad swathe in one course, a plurality of blades (12, 14, 16) of the above-mentioned type are arranged adjacent one another. In order to increase the efficiency of the comminution process, the covers (46) have passages (48) for the mowed material. Peripheral walls (50) of the covers (46) widen tangentially in the sense of rotation (U) towards the passages (48) so that the effective width (d) of the passages (48) for mowed material moving in a tangential direction is as wide as possible.
Patent DK-0755777-T3 (DK)
Inventor: GASSE ANDREAS DR
IPC: B32B27/08
Filed: 1996-06-17
Granted: 2002-02-04
Abstract: Low friction, sealable composite films (F) with very good deep draw properties, based on polyamide and polyolefins, comprising the following layers: (A) at least one aliphatic polyamide layer; (B) at least one layer of polymer blend comprising 10-60 wt.% amorphous polyamide and 40-90 wt.% aliphatic polyamide; (C) at least one thermoplastic sealing layer; and (D) at least one bonding layer. (F) are non-oriented and the outer surfaces comprise layers of (A) and (C).
Patent DK-0821685-T3 (DK)
Inventor: SHEPPARD GEORGE S
IPC: A61K31/435
Filed: 1996-03-25
Granted: 2002-01-21
Abstract: The present invention provides compounds of formula   <IMAGE>  +TR   <IMAGE>   and the pharmaceutically acceptable salts thereof which are potent antagonists of PAF and are useful in the treatment of PAF-related disorders including asthma, shock, respiratory distress syndrome, acute inflammation, transplanted organ rejection, gastrointestinal ulceration, allergic skin diseases, delayed cellular immunity, parturition, fetal lung maturation, and cellular differentiation.
Patent DK-0826093-T3 (DK)
Inventor: WIDEN BO
IPC: E05B9/08
Filed: 1996-05-17
Granted: 2002-03-18
Abstract: A removable core cylinder lock includes a cylinder lock casing and a removable cylinder lock core inserted into the casing. The lock core has an upper massive part with a row of holes for accommodating locking tumblers, and a lower part defining a cylindrical bore in which a cylindrical, rotatable key plug is located. The lower part defining the cylinder bore of the cylinder lock core is partially cut away so as to form an axially elongated chamber accommodating a transversely movable retainer member and leaving a continuous lower wall portion. The retainer member has an axial length, which corresponds to at least half of the axial length of the row of holes in the upper massive part, and a limited circumferential extension, which is substantially supplementary to the continuous lower wall portion so as to define the cylindrical bore.
Patent DK-0830608-T3 (DK)
Inventor: CAMPBELL PAULA A
IPC: G01N33/50
Filed: 1996-06-06
Granted: 2000-11-20
Abstract: The present invention provides a method for determining thrombotic risk in an individual. The method involves determining the activity of Protein C and Protein S in the plasma of the individual thought to be at thrombotic risk by adding to a plasma sample obtained from the individual (i) a first reagent in an amount sufficient to induce or activate coagulation in the plasma, (ii) a second reagent which activates endogenous protein C in the plasma, and (iii) a third reagent comprising calcium salts, phospholipids or tissue thromboplastin, or a combination thereof. To a second plasma sample from the same subject is added a reagent which induces or activates coagulation, and a buffer or other material which does not activate protein C, and a third reagent as described above. The time, rate or both, necessary for the conversion of endogenous fibrinogen to fibrin in both the first and second samples is measured. The same steps are performed on normal control plasma, and the difference or ratio in the times, rates, or both, obtained above are determined. The difference or ratio is indicative of the thrombotic risk in the subject. A kit adapted to carry out the method also is the subject of the present invention. The methods and kits of the invention in other embodiments may comprise a first reagent comprising a synthetic substrate, a second reagent which in the first sample from the subject activates protein C, and in the second sample, a second reagent which does not activate protein C. In these embodiments, the rates of hydrolysis of the synthetic substrates are measured and compared.
Patent DK-0873319-T3 (DK)
Inventor: LOHMANN JEAN-JACQUES MARCEL ZE
IPC: C07D239/74
Filed: 1996-12-13
Granted: 2001-10-22
Abstract: The invention relates to quinazoline derivatives of the formula: [wherein: Y1 represents -O-, -S-, -CH2-, -SO-, -SO2-, -NR5CO-, -CONR6-, -SO2NR7-, -NR8SO2- or -NR9- (wherein R5, R6, R7, R8 and R9 each independently represents hydrogen, alkyl or alkoxyalkyl); R1 represents hydrogen, hydroxy, halogeno, nitro, trifluoromethyl, cyano, alkyl, alkoxy, alkylthio, amino or alkylamino. R2 represents hydrogen, hydroxy, halogeno, alkyl, alkoxy, trifluoromethyl, cyano, amino or nitro; m is an integer from 1 to 5; R3 represents hydroxy, halogeno, alky, alkoxy, alkanoyloxy, trifluoromethyl, cyano, amino or nitro; R4 represents a group which is or which contains an optionally substituted pyridone, phenyl or aromatic heterocyclic group] and salts thereof; processes for their preparation and pharmaceutical compositions containing a compound of formula I or a pharmaceutically acceptable salt thereof as active ingredient. The compounds of formula I and the pharmaceutically acceptable salts thereof inhibit the effects of VEGF, a property of value in the treatment of a number of disease states including cancer and rheumatoid arthritis.
Patent DK-0784415-T3 (DK)
Inventor: SALVAGE RICHARD JAMES
IPC: H04R11/00
Filed: 1993-10-15
Granted: 2002-08-19
Abstract: This invention relates to electroacoustic transducers which incorporate a reed armature 17. Formations (25, 26, 27, 28 and 29) are provided for mounting the deflection of the reed 17. <IMAGE>
Patent DK-1084451-T3 (DK)
Inventor: GOODHILL DEAN K
IPC: G03B31/02
Filed: 1998-04-27
Granted: 2004-08-16
Abstract: A method of making motion picture release-print film, such as 35 mm film. The film has an enlarged frame that occupies substantially the entire width of the film that is available for the exposure of images, and the spacing between frames is minimized. Film having these enlarged frames provides an enhanced image with a minimum of film waste. Aspect ratios of 1.85:1 and 2.01:1 in the enlarged frame size are contemplated in three and four perforation formats. A digital soundtrack or other appropriate soundtrack replaces the analog soundtrack that occupies a portion of the available width. The soundtrack may provide for redundancy.
Patent DK-1076315-T3 (DK)
Inventor: MINNETIAN OHANNES
IPC: G06K19/06
Filed: 1999-08-12
Granted: 2005-05-23
Abstract: Data carrier has injection moulded, plastic protective layer which covers security element (3) and at least part of information side to enclose security element between substrate and protective layer seamlessly. Protective layer has same thickness of substrate and substrate and/or protective layer are transparent. INDEPENDENT CLAIM included for process to manufacutre composite layers for data carrier.
Patent DK-1004241-T3 (DK)
Inventor: TAKASUGI JAMES JAN
IPC: A01N47/38
Filed: 1999-11-17
Granted: 2004-05-24
Abstract: The present invention relates to 2-aryl- DELTA <2>-1,3,4-(oxa and thia)diazoline compounds having the structural formula <CHEM> and compositions and methods comprising those compounds for the control of insect and acarid pests.